bioAffinity Technologies (BIAF) Stock Price
bioAffinity Technologies Price
Revenue has compounded at 728.8% per year over the past 4 years to 6.16 M USD. bioAffinity Technologies's net margin stands at -242.0%, up from -484,411.4% several years earlier. Analysts set a median price target of 6.12 USD, implying 0.6% below the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
bioAffinity Technologies stock price
bioAffinity Technologies business model & stock analysis
Frequently asked questions about bioAffinity Technologies
Analysts currently set an average price target of 6.12 USD for the bioAffinity Technologies stock (median: 6.12 USD), implying -0.6 % versus the latest price. The consensus is based on 7 analyst ratings.
6 analysts currently rate the bioAffinity Technologies stock: 0 recommend buying, 3 holding and 3 selling. For 2026, analysts expect bioAffinity Technologies to generate revenue of 7.31 M USD and earnings per share of -317.79 USD.
Converted at the current exchange rate, the bioAffinity Technologies share trades at 5.50 EUR (6.16 USD).
The expected revenue of bioAffinity Technologies is 7.31 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of bioAffinity Technologies is -36.45 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of bioAffinity Technologies is currently -0.02. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the bioAffinity Technologies stock.
The price-to-sales ratio (P/S) of bioAffinity Technologies is currently 0.10. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the bioAffinity Technologies stock.
The Eulerpool Quality Score for bioAffinity Technologies is 3/10.
The ISIN of bioAffinity Technologies is US09076W3079. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of bioAffinity Technologies is BIAF. The ticker symbol is used to trade bioAffinity Technologies shares on the stock exchange.
bioAffinity Technologies stock
bioAffinity Technologies Peer Group
All fundamentals and in-depth analysis of bioAffinity Technologies
Our stock analysis for bioAffinity Technologies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of bioAffinity Technologies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.